wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35557435-723CAB52-7444-4FE3-A633-67DFD888289F
Q35557435-723CAB52-7444-4FE3-A633-67DFD888289F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35557435-723CAB52-7444-4FE3-A633-67DFD888289F
Switching from body surface area-based to fixed dosing for the investigational proteasome inhibitor ixazomib: a population pharmacokinetic analysis.
P2860
Q35557435-723CAB52-7444-4FE3-A633-67DFD888289F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35557435-723CAB52-7444-4FE3-A633-67DFD888289F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4ded59ccc6d520123046ad01e38e7d93eabcf5e5
P2860
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.